A History of Targeted Therapy Development and Progress in Novel-Novel Combinations for Chronic Lymphocytic Leukemia (CLL)

Karr, M; Roeker, L

Roeker, L (通讯作者),Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, New York, NY 10065 USA.

CANCERS, 2023; 15 (4):

Abstract

Simple Summary The treatment landscape for CLL has changed dramatically since the advent of targeted therapies. Studies have shown clear progression-f......

Full Text Link